DNA mutations in cholangiocarcinoma: targeting IDH1 and other mutations

Valery, M; Cervantes, B; Smolenschi, C; Boige, V; Ducreux, M; Cohen, R; Hollebecque, A

Valery, M (通讯作者),Gustave Roussy, Dept Med Oncol, F-94805 Villejuif, France.

BULLETIN DU CANCER, 2022; 109 (11): 11S21

Abstract

Biliary tract cancers (BTC) are rare cancers with a poor prognosis, particularly at the metastatic stage, with a 5-year survival rate not exceeding 7%......

Full Text Link